Navigation Links
Van Andel Institute and Children's Memorial Research Center of Chicago Form a Partnership to Facilitate Pediatric Research
Date:2/26/2008

XenoBase software can be used to develop more effective treatments for pediatric patients

GRAND RAPIDS, Mich., Feb. 26 /PRNewswire-USNewswire/ -- Van Andel Institute (VAI) has entered into a multi-year licensing agreement with Children's Memorial Research Center (CMRC) of Chicago for use of its XenoBase software and database system.

XenoBase is a unique, advanced bio-informatic system created by scientists at Van Andel Research Institute (VARI) to support all aspects of the life sciences from basic research discovery to clinical application. The platform holds great promise for researchers and clinicians who use the system to explore the molecular and clinical basis of disease. In recent applications, physicians have used the tool to match the molecular profile of tumors of late-stage cancer patients to the most effective therapy, based on molecular evidence.

"The XenoBase technology holds great promise for the future as we evolve toward a more proactive standard of health care," said VAI Chairman & CEO David Van Andel. "We are pleased to enter into this agreement with an internationally recognized research center under the fine leadership of Dr. Hendrix who is dedicated to producing innovative solutions to prevent, diagnose and treat diseases affecting children."

CMRC is the research arm of Children's Memorial Hospital (CMH), the pediatric teaching hospital for Northwestern University's Feinberg School of Medicine. It is one of only a handful of institutions in the United States dedicated exclusively to pediatric research. Like the researchers at VARI, the research team of CMRC will use XenoBase to explore the molecular and clinical basis for disease and to support the discovery of novel approaches to alleviate pain and suffering due to disease.

"As a result of this agreement between CMRC and VARI, we anticipate novel collaborations using XenoBase to more quickly impact human disease," said Mary J.C. Hendrix, Ph.D., Medical Research Institute Council Endowed Chair for the President and Scientific Director of CMRC.

XenoBase is the result of five years of research and development in the lab of Craig P. Webb, Ph.D., Director of VARI's Program of Translational Medicine. The system can collect and analyze a wide range of molecular and conventional clinical data to aid researchers in identifying associations between diseases, biomarkers and treatment outcomes. "We are delighted to license this technology to CMRC and demonstrate its effectiveness in supporting different areas of pediatric translational research," said Webb. "We look forward to collaborative efforts through which improved diagnostic and therapeutic strategies can ultimately be introduced to the pediatric population."

The mission of Children's Memorial Research Center is to generate new knowledge leading to advancements in the prevention, diagnosis, and treatment of diseases that affect the development of children through adolescence as well as adult disorders that derive from them. Our multidisciplinary teams of physicians, scientists, technicians, nurses and trainees are committed to making discoveries that will improve the lives of children and their families.

Established by Jay and Betty Van Andel in 1996, Van Andel Institute is an independent research organization dedicated to preserving, enhancing and expanding the frontiers of medical science, and to achieving excellence in education by probing fundamental issues of education and the learning process.


'/>"/>
SOURCE Children's Memorial Hospital
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
2. Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
3. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
4. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
5. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
6. China Holdings Announces Starwood Research Institute Initiates Research Coverage
7. OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
8. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
9. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
10. VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
11. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet ... in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition ... lives. “We are prolonging life 6 years in the last 3 decades,” says ...
(Date:12/2/2016)... ... 02, 2016 , ... Universal Medical Systems, Inc. (UMS) the ... company to offer robotic imaging to veterinary medicine is sponsoring the appearance of ... the American Association of Equine Practitioners 62nd Annual Convention from December 4-6, 2016 ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Yisrayl Hawkins, at ... into how this current generation fits into Bible Prophecy. Yisrayl says this generation, known ... pointing to this conclusion, showing how the details line up exactly with Bible Prophecy ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)...  PipelineRx, a leading medication management technology company ... of its SaaS-based telepharmacy platform, PowerGridRx™ , ... Midyear Clinical Meeting and Exhibition, December 5-7 in ... 300 hospital clients nationally, the Company is a ... dramatically improve pharmacy operations, enhance patient safety, and ...
(Date:12/2/2016)... 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today announced ... ("PSI").  The combination of Texas -based Maxor ... PSI bring together both company,s clinical expertise and high-touch patient ... industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... 2, 2016 Lianluo Smart Limited (Nasdaq: ... Company") which develops, markets and sells medical devices ... China and international markets, recently attended ... Treatment New Progress Forum, co-hosted by the Institute ... , Guangdong Provincial People,s Hospital and Cardiology ...
Breaking Medicine Technology: